Artificial intelligence continues to reshape healthcare with novel applications in patient care and diagnostics. Boston's Cascala Health secured $8.6 million to expand its AI platform that predicts patient risks during care transitions, aiming to reduce hospital readmissions and costs. Separately, a study introduced 'ColoViT,' a fusion of EfficientNet and vision transformers, enhancing early colon cancer detection accuracy. Additionally, AI identified bufalin as a new estrogen receptor degrader, illustrating AI's growing role in drug discovery.